Would you pay $1 million to enroll in a phase 1 clinical trial of an “anti-aging” gene therapy? Science-Based Medicine, 02 Dec 2019 Libella Gene Therapeutics, LLC made the news last week for announcing a "pay-to-play" trial of its telomerase-based anti-aging…